Our findings revealed that AAPR (P = 0.023), tumor histological grade (P = 0.010), HER2 status (P = 0.038), and changes in tumor blood supply (P = 0.032) independently predicted pCR in BC patients after NACT. The gene discussed is ERBB2; the disease is breast cancer.